Drugs
Long Island's elderly population is facing an alarming trend of exorbitant prescription drug prices, with many seniors forced to choose between paying for their medications and purchasing food. A study conducted by the House of Representatives Committee on Government Reform found that consumers who pay for their own
Drugs
The White House's Medicare reform proposal, announced by President Clinton, has been met with skepticism due to discrepancies between the administration's cost estimates and those of the nonpartisan Congressional Budget Office (CBO). The CBO predicts a $50 billion higher cost for the proposed prescription drug benefit,
Drugs
AstraZeneca is expected to dispose of its herbicide and fungicide arm, citing a lack of synergy with its human medicines business and growing frustration with the genetically modified food controversy. The unit, Zeneca Agrochemicals, is doing better than some rivals, but profits are down sharply. Despite this, the fast-growing Amistar
Drugs
Shire Pharmaceuticals, a UK-based drugs company, is poised to announce a major merger with Roberts Pharmaceutical Corporation, a US-based marketing-led drugs company. The deal, worth £1.5 billion, aims to create a global pharmaceutical giant. Shire's CEO, Rolf Stahel, is expected to lead the enlarged group, despite the
Drugs
Shire Pharmaceuticals, a leading British drug company, is set to announce a massive merger with US-based Roberts Pharmaceuticals. The deal, reportedly an all-share merger, would bring together two of the world's fastest-growing speciality drugs companies, further solidifying Shire's position as a major player in the industry.
Drugs
The House of Delegates has reaffirmed its interest in FDA regulation of supplements and herbal remedies in response to continued physician concern about their potential risks to patients. A growing number of patients are experimenting with these products, some of which offer true therapeutic benefits while others harm patients. The
Drugs
STC Technologies, Inc. (STC) has announced that it has received clearance from the Food & Drug Administration (FDA) to market its Histofreezer(R) Portable Cyrosurgical System for the treatment of actinic keratoses and lentigo, common premalignant skin tumors and age spots, respectively. This clearance marks a significant milestone for STC,
Drugs
Mitsubishi Chemical, Japan's largest integrated chemicals maker, is striving to achieve a return on assets of 4% by 2002-03 on a consolidated basis. This ambitious goal is part of the company's new three-year business plan, which is expected to be drawn up by the end of
Drugs
Yesterday, Rhone-Poulenc shareholders voted overwhelmingly in favor of a merger with Hoechst, a move that will create one of the world's largest life sciences companies. The Paris meeting saw an impressive 99.5 per cent of shareholders approve the resolution, with all proposed resolutions securing more than 97
Drugs
Organon Inc., a leading international ethical pharmaceutical company, has been recognized by RESOLVE of New Jersey for its dedication to helping couples in the state and worldwide realize their dream of having children through assisted reproductive technology (ART). The company's support of advocacy efforts and commitment to providing
Drugs
Sanofi-Synthelabo and Bayer Belgium have announced a significant partnership with Dendrite, a leading global provider of sales force effectiveness (SFE) solutions. The two pharmaceutical companies have signed three-year licensing agreements with Dendrite, cementing their commitment to leveraging advanced technology and expertise to drive sales success. Sanofi-Synthelabo, the second-largest French pharmaceutical
Drugs
Federal regulators are sounding the alarm about potential vulnerabilities in computer software used in laboratories, with FDA officials expressing concerns about systems that cannot detect or prevent data tampering. Pharmaceutical companies are being warned to ensure that their computer systems can detect and track changes to laboratory records, a crucial
